Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Saba K et al. The Journal of Pathology Clinical Research 2020:6:231-237

By anette [dot] welin [at] med [dot] lu [dot] se (Anette Welin) - published 19 February 2021

This article is over 5 years old, and the information may therefore be outdated.

Foto. Karim Saba.

Saba K et al. The Journal of Pathology Clinical Research 2020:6:231-237

Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma. Saba KH, Cornmark L, Hofvander J, Magnusson L, Nilsson J, van den Bos H, Spierings DC, Foijer F, Staaf J, Brosjö O, Sumathi VP, Lam SW, Szuhai K, Bovée JVMG, Kovac M, Baumhoer D, Styring E, Nord KH. The Journal of Pathology Clinical Research 2020 doi: 10.1002/cjp2.172. Online ahead of print.

Latest news

Share

Last updated: 19 Feb 2021